Carvedilol ER 10 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FADWL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,439
Award facts
- Contract value 100% obligated
- $38,439.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,439.46 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count packaging) on January 29, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.999 billion through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated significant capability in fulfilling government pharmaceutical supply requirements through its extensive portfolio of competitive contract awards with the DLA Medical Supply Chain. The company supplies a broad range of pharmaceutical products across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for carvedilol, a cardiovascular medication commonly prescribed for heart failure and hypertension treatment, reflects the company's ongoing role as a primary supplier of essential medications to the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FADWL?
SPE2DR26FADWL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FADWL worth?
The government has obligated $38,439 on SPE2DR26FADWL.
Is contract SPE2DR26FADWL an order under another contract?
Yes. SPE2DR26FADWL is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADWL competed?
The extent of competition for SPE2DR26FADWL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award